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Abstract
Background: Chlamydia trachomatis is a major cause of sexually transmitted disease in humans. Previous studies in
both humans and animal models of chlamydial genital tract infection have suggested that the hormonal status of
the genital tract epithelium at the time of exposure can influence the outcome of the chlamydial infection. We
performed a whole genome transcriptional profiling study of C. trachomatis infection in ECC-1 cells under
progesterone or estradiol treatment.
Results: Both hormone treatments caused a significant shift in the sub-set of genes expressed (25% of the
transcriptome altered by more than 2-fold). Overall, estradiol treatment resulted in the down-regulation of 151
genes, including those associated with lipid and nucleotide metabolism. Of particular interest was the up-
regulation in estradiol-supplemented cultures of six genes (omcB, trpB, cydA, cydB, pyk and yggV), which suggest a
stress response similar to that reported previously in other models of chlamydial persistence. We also observed
morphological changes consistent with a persistence response. By comparison, progesterone supplementation
resulted in a general up-regulation of an energy utilising response.
Conclusion: Our data shows for the first time, that the treatment of chlamydial host cells with key reproductive
hormones such as progesterone and estradiol, results in significantly altered chlamydial gene expression profiles. It
is likely that these chlamydial expression patterns are survival responses, evolved by the pathogen to enable it to
overcome the host’s innate immune response. The induction of chlamydial persistence is probably a key
component of this survival response.
Background
Chlamydia trachomatis is an obligate intracellular bac-
terial pathogen that infects the genital and ocular
mucosa of humans causing sexually transmitted disease
and trachoma respectively. In 2010 the World Health
Organization reported 140 million cases of C. trachoma-
tis infections occurred worldwide [1]. In females, C. tra-
chomatis is a common cause of cervicitis, urethritis,
with sequelea including ectopic pregnancy, pelvic
inflammatory disease, tubal factor infertility, proctitis
and chronic pelvic pain. In males, C. trachomatis infec-
tions can lead to urethritis, epididymitis and orchitis
and it may also contribute to male infertility by directly
damaging the sperm [2]. Since approximately 75% of
C. trachomatis infections in women are asymptomatic,
research efforts are mainly focused on females [1,3].
Studies using animal models of genital tract Chlamy-
dia infection suggest that the hormonal status of the
genital tract epithelium at the time of exposure may
influence the outcome of infection. For example, in the
commonly used mouse model involving C. muridarum
infection, pre-exposed of animals with progesterone is
required to achieve infection of 100% of the animals
[4,5]. Conversely, guinea pigs are more susceptible to
infection following pre-treatment with estradiol [6].
Using a rat model, Kaushic et al. [7,8] found that in rats
infected at either estrus or diestrus, without progester-
one pre-treatment, no chlamydial inclusions were
observed in either the uterus or vagina. In an in vitro
model of infection of HeLa cells with C. trachomatis,
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ence of chlamydial elementary bodies to the cells as well
as the development of chlamydial inclusions [9]. Oral
contraceptive use also increases the risk of contracting
chlamydial infections compared to women not using
contraception [10]. Collectively, these data show that
the outcome of chlamydial infection is determined in
part by the hormonal status of the epithelium at the
time of exposure.
In many cases, chlamydial diseases are associated
with a long term or chronic infectious state. In most
cases it is difficult to establish whether chronic or
recurrent infections arise through the inability of the
host to resolve the initial infection or the occurrence
of repeated infections with similar species or geno-
types. Despite the unresolved nature of the disease
etiology, persistence models of chlamydial infection
have been studied to provide insight into the nature of
chronic disease. Chlamydial persistence is defined as a
long-term association between Chlamydia and their
host cell in which these organisms remain in a viable
but culture-negative state [11,12]. Chlamydial persis-
tence is thought to be due in part to a failure to
undergo secondary differentiation from RB to EB.
Molecular consequences include a ‘blockage’ in devel-
opment involving down-regulation of late gene pro-
ducts in persistent infections [13]. The in vitro
persistence systems often share altered chlamydial
growth characteristics, for example, many studies have
described enlarged, and pleomorphic RBs that neither
undergo binary fission, nor differentiate back to EBs,
but nevertheless continue to replicate their chromo-
somes. Persistent in vitro infections have been induced
by penicillin treatment, amino acid starvation, iron
deficiency, Interferon-gamma (IFN-g)e x p o s u r e ,m o n o -
cyte infection, phage infection and continuous culture
[12-14]. However, a persistence phenotype has not pre-
viously been reported to occur in response to altered
levels of sex hormones.
Previous data have demonstrated that the metabolic
characteristics of persistent chlamydiae were not the
same as those of actively growing organisms [12,15-17].
The results reported from Gerard et al. [18] indicated
that during the primary phase of active infection, C. tra-
chomatis obtain the energy essential for EB to RB trans-
formation, and also for metabolism, from host cells via
ATP/ADP exchange. Through active growth of the RB,
the organisms acquire ATP not only from the host, but
a l s ov i at h e i ro w ng l y c o l y t i ca n dp e n t o s ep h o s p h a t e
pathways. Gerard et al. (2002) determined that through-
out the initial phase of monocyte infection, prior to the
complete establishment of persistence, C. trachomatis
cells utilized both ATP/ADP exchange and their own
pathways to support metabolic needs, even though the
overall metabolic rate in the organisms was relatively
low. However, when persistence has been established
t h eo n l ys o u r c eo fA T Pa p p e a r st ob et h eh o s t[ 1 8 ] .
This was supported by the finding that, mRNA for gly-
colytic and pentose phosphate pathway enzymes were
absent or severely reduced, suggesting that these sys-
tems were partially, if not completely, shut down
through persistence. Therefore, C. trachomatis seemed
to be merely partial energy parasites on their hosts dur-
ing active growth, however during persistent infection
the organisms appeared to be completely dependent on
the host for ATP.
In the current study, we utilised a whole genome
microarray to study the changes in chlamydial transcrip-
tional response in in vitro cultured C. trachomatis
exposed to either progesterone or estradiol. We found a
potentially counter-balancing effect of the two hormones
on the chlamydial response.
Methods
Hormone supplementation of Chlamydia-infected cells
ECC-1: The ECC-1 is a well-differentiated, steroid
responsive human endometrial cell line, which was
maintained in phenol red-free 1× Dulbecco’s Modified
Eagle Medium/Ham’s F12 nutrient mix (DMEM/F12 -
1:1) (Invitrogen, Carlsbad, CA, USA).
HEp-2: The HEp-2 cell line is a human epithelial cell
line, which was maintained in 1× DMEM containing
phenol red, 4.5 g/L D-glucose, 110 mg/L sodium pyru-
vate, and 584 mg/L L-glutamine, and supplemented
with 500 U/ml penicillin G sodium/5,000 μg/ml strepto-
mycin sulphate (Invitrogen).
Hormone preparation
Lyophilised progesterone and 17b-estradiol (Sigma-
Aldrich, St. Louis, MO, USA) were solubilised in abso-
l u t ee t h a n o lt o1m g / m ls t o ck. Serum levels of female
sex hormones, estradiol and progesterone, fluctuate
throughout the menstrual cycle. In this study mean phy-
siological concentrations of 17b-estradiol (200 pg/ml)
and progesterone (20 ng/ml), adapted from Williams
Textbook of Endocrinology were further diluted using
phenol red-free 1× DMEM/F12 medium (Invitrogen),
supplemented with 10% charcoal/dextran-treated FBS
(Hyclone). Once the ECC-1 cells had reached 100% con-
fluence, average physiological concentrations of 17b-
estradiol, progesterone, and a combination of 17b-estra-
diol and progesterone (1:1) were added to respective
flasks. This hormone exposure was continued through-
out the duration of chlamydial infection. Although the
physiological concentration of progesterone is higher
than estradiol, in this study a combination of 1:1, estra-
diol and progesterone, was chosen as starting point to
merely determine the effect of both hormones together.
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of experiments.
C. trachomatis serovar D growth and propagation
C. trachomatis serovar D was grown, maintained and
further propagated to create C. trachomatis serovar D
stock. C. trachomatis was semi-purified from the
infected HEp-2 cells via sonication and vortexing. ECC-
1 cells were used for C. trachomatis serovar D titration.
Infected cells were stained utilising the CelLabs Chlamy-
dia Cel LPS staining kit, containing the fluorescein iso-
thiocyanate (FITC)-labelled mouse monoclonal antibody
specific for chlamydial lipopolysaccahride (LPS) (Cel-
Labs, Brookvale, Australia), according to manufacturer’s
instructions.
RNA Extraction
Total RNA was extracted 48 hrs post infection from
infected ECC-1 cells using the Trizol
® reagent protocol
(Invitrogen) and then treated with DNase. Eukaryotic
RNA was removed from total RNA using the Dynabead
(poly A
+ purification kit) (Dynal Biotech ASA, Oslo,
Norway) according to manufacturer’si n s t r u c t i o n sa n d
the bacterial mRNA re-suspended in DEPC water.
Approximately 2 μl of the bacterial mRNA solution was
removed to determine the quality and quantity of RNA,
using a NanoDrop
® Spectrophotometer (NanoDrop
Technologies
®, Wilmington, DE, USA) and associated
NanoDrop ND-1000 3.2.1 software (Coleman Technolo-
gies Inc., Glen Mills, PA, USA). Extracted RNA was
determined to be of high purity, as indicated by the
absorbance ratio (A260:A280) being very close to 2.00.
T h eq u a n t i t yo fR N Ae x t r a c t e d indicated amplification
was not required prior to microarray analysis as
the concentration of RNA was sufficient for our
experiments.
Whole transcriptome analysis by Affymetrix microarray
The bacterial mRNA was sent to the AGRF (Australian
Genome Research Facility, Melbourne, Australia) for
microarray analysis. In vitro RNA transcription was
performed to incorporate biotin-labelled ribonucleo-
tides into the cRNA transcripts using the ENZO RNA
transcript labelling kit. Labeled cRNAs were purified
using the Qiagen kit (according to manufacturer’s
instructions) and then fragmented to approximately 50
to 200 bp by heating at 94°C for 35 min. Fifteen
micrograms (15 μg) was then hybridized to a Chlamy-
dia whole genome Affymetrix Custom array. The array
is an Affymetrix oligonucleotide array format of 1800
features, covering the full C. trachomatis genome (875
genes) and containing 8-11 oligonucleotides per target
gene, each designed for optimal hybridization to C.
trachomatis and/or C. pneumoniae and screened for
non-specific hybridization against the full human and
mouse genomes. After hybridization and subsequent
washing using the Affymetrix Fluidics station 400, the
bound cRNAs were stained with streptavidin phycoery-
thrin, and the signal amplified with a fluorescent-
tagged antibody to streptavidin (Performed by AGRF).
Fluorescence was measured using the Affymetrix scan-
ner and the results analysed using GeneChip 1.4 analy-
sis software, resulting in the detection of 1175 genes.
A total of 16 chlamydial arrays were analysed with the
4 culture conditions (no hormone, E, P, E+P) × four
replicates. The entire microarray data recorded in
Gene Expression Omnibus (GEO) database with acces-
sion number GSE24119.
Quantitative RT-PCR
Quantitative Real-Time PCR was used to validate the
microarray data for 20 selected target genes. Each pri-
mer pair was used to generate amplicon standards by
amplifying previously generated C. trachomatis cDNA.
cDNA generation was performed using the Super-
Script
® III Reverse Transcriptase technique (Invitro-
gen, Carlsbad, CA, USA). One μg of template was
added to the PCR mixture containing 0.15 μMo fg e n e
specific forward and reverse primers, 1 × SYBR Green
reaction mastermix, before being made up to a final
volume of 25 μL with distilled water. The mix is opti-
mized for SYBR Green reactions and contains SYBR
Green I dye, AmpliTaq DNA Polymerase, dNTPs and
optimized buffer components. Cycling parameters for
all reactions were as follows: denaturation at 95°C for
10 min; 40 cycles of denaturation at 95°C for 15 sec
and 1 min of annealing and extension at 60°C; and
melting curve analysis from 60°C to 95°C. The Rotor-
Gene 6000 fast real-time PCR system (Corbett) was
used for relative quantification of cDNA copies for the
20 selected genes and an internal reference gene (16S
rRNA) was used in all experiments. Quantitation was
carried out by using a standard curve based on serial
dilutions of the amplicon standards covering 6 logs.
Real-time PCR templates for each gene of interest
included fresh dilutions of the amplicon standards, 8
cDNA samples (2 × 4 samples per experiment) and
distilled water as a negative control. All reactions were
performed in triplicate. Reaction tube mastermixes
were prepared as per the preparation of amplicon stan-
dards described above.
Each gene array profile indicated the expression level
of each gene under the differing experimental condi-
tions. To identify genes with similar expression profiles
mathematical clustering methods were used, with the
resulting hierarchy displayed as dendrograms. 16s rRNA
was used as an internal control. The use of an internal
control was necessary as the number of genes expressed
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and no single gene was constitutively expressed. This
method of normalization was particularly important in
comparing samples grown in charcoal-stripped, hor-
mone-free media to those in hormone-supplemented
cultures.
Microarray data accession number
The entire microarray data recorded in Gene Expression
Omnibus (GEO) database with accession number:
GSE24119.
Results and discussion
Whole transcriptome microarray data confirmed by qRT-
PCR analyses
We used a whole genome Affymetrix microarray
approach to measure the transcriptional responses of
C. trachomatis grown in ECC-1 cells supplemented
with the female sex hormones, estradiol and progester-
one. The resultant data was extracted and filtered
through Affymetrix’sG e n eC h i pO p e r a t i n gS y s t e m
(GOCS) version 1.4, and processed using the MAS5
algorithm. Candidate lists of genes were further refined
by selecting genes with a greater than 2-fold up/down-
regulation and a p-value of <0.05. Replicate data sets
were processed individually and then cross-correlated
with each other to find statistically significant changes
in gene expression. A total of 16 chlamydial arrays
were analysed, with the four culture conditions (no
hormone, E, P, E+P), enabling us to have four repli-
cates for each test condition. To confirm the accuracy
and reliability of our microarray data, we chose 19
genes that were either up or down-regulated by micro-
array for analysis by quantitative RT-PCR (Table 1).
For 17 of these 19 genes there was complete agree-
ment between the microarray results and the qRT-PCR
results. In all cases the fold changes measured by qRT-
PCR were larger than those recorded using the micro-
array assay. For the two genes that were not consistent
between the two methodologies, the microarray
method gave a down-regulation of transcription
whereas the qRT-PCR method showed no change in
the transcriptional response.
Approximately 25% of the C. trachomatis transcriptome is
altered in response to estradiol or progesterone exposure
in vitro
A significant percentage (approximately 25%) of the C.
trachomatis transcriptome was altered in response to
both hormones. Using a 2-fold change as a cut-off, 63
genes (7%) were up-regulated in response to estradiol
while 151 genes (17%) were down-regulated (Table 2). A
similar percentage (but different subset) of the transcrip-
tome was altered under progesterone exposure, with 85
genes (10%) being up-regulated and 135 genes (15%)
being down-regulated. This represents around 25% of
the transcriptome as a whole, being altered by either
hormone alone. When the cut-off was set at 3-fold, 18-
20% of the transcriptome was still changed in response
to the sex hormones, but this level dropped to 12%
when a 5-fold cut-off is used. The full microarray data-
set is provided in the GEO database.
Estradiol exposure results in the specific down-regulation
of lipid and nucleotide metabolism pathways
In the estradiol-exposed cultures, 151 genes were
down-regulated more than 2-fold, while 63 genes were
Table 1 Comparison of expression folds change obtained
by microarray analysis with fold change obtained by
qRT-PCR.
Gene name Affymetrix fold change qRT-PCR fold change
gseA 13.30 up 27.94 up
nqr2 9.20 up 17.32 up
ytgD 9.05 up 14.07 up
ydaO 5.98 up 12.51 up
pdhA 5.78 up 17.30 up
recA 4.12 up 7.92 up
lplA 2 3.89 up 7.41 up
trpB 3.80 up 11.87 up
incA 3.10 up 18.04 up
fli1 2.25 up 6.80 up
sdhB 22.53 Down 6.8 Down
trxB 31.44 Down 5.19 Down
pyrH 21.54 Down No change
miaA 33.91 Down 11.74 Down
cysS 19.09 Down 7.03 Down
nrdA 30.06 Down 5.16 Down
pbp3 33.53 Down 9.43 Down
ychF 21.29 Down No change
yggV 31.84 Down 12.11 Down
Table 2 Summary of Chlamydia trachomatis up-regulated
and down-regulated genes in response to estradiol or
progesterone exposure.
Estradiol Progesterone
No. of genes/%
of genome
No. of genes/%
of genome
Up regulated
A: > 2-fold, change 63 (7%) 85 (10%)
B: > 3-fold change 52 (6%) 77 (9%)
C: > 5-fold change 22 (2.5%) 49 (5.5%)
Down regulated
A: > 2-fold, change 151 (17%) 135 (15%)
B: > 3-fold change 138 (15.7%) 117 (13%)
C: > 5-fold change 98 (11%) 81 (9%)
(A) 2-fold cut-off, (B) 3-fold cut-off, (C) 5-fold cut-off.
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Of these 213 altered genes, more than 52% were
hypothetical proteins, with no known homologues out-
side the chlamydiae. Even though nearly 30% of the
chlamydial genome is composed of hypothetical genes,
the fact that 52% of these genes altered their expression
by more than 2-fold in response to estradiol exposure
suggests that many of the key changes are uniquely
associated with Chlamydia. The five top up-regulated
genes (ie. showing the largest fold change) included
the Nqr2 subunit of Na-translocating NADH-quinone
reductase complex (nqr2) [9.26 fold], UDP-N-acetyl-
muramoylalanine-D-glutamate ligase, putative (murC/
ddlA) [9.31 fold], V-type ATPase, subunit D, putative
(atpD) [10.23 fold], arginine transport system sub-
strate-binding protein (artJ) [10.96 fold], and putative
glycerol-3-phosphate acyltransferase (plsX) [16.53 fold].
In addition, the five genes that showed the largest
down-regulation of mRNA expression profile include
cell division protein FtsI (pbp3) [35.54 fold], nucleo-
side-triphosphatase (yggV) [31.84 fold], ribonucleoside-
diphosphate reductase alpha chain (nrdA)[ 3 0 . 0 6f o l d ] ,
GTP-dependent nucleic acid-binding protein (ychF)
[21.29 fold], and succinate dehydrogenase iron-sulfur
subunit (sdhB) [18.82 fold].
When the up- and down-regulated genes were input
into the KEGG Pathway database http://www.genome.
jp/kegg/pathway.html, using the known or predicted
chlamydial pathway information, some clustering of
transcriptional responses was evident (Table 3). Estra-
diol clearly induced an overall down-regulation of chla-
mydial fatty acid biosynthesis, with seven genes being
down-regulated at least 2-fold (accB, fabF, lipA, fabG,
lplA_2). Estradiol also resulted in a marked down-regu-
lation of the genes involved in chlamydial nucleotide
(purine and pyrimidine) metabolism (adk, dnaE, dut,
nrdA, surE, yggV, rpoC, ygfA, dut). In addition, we also
observed a more minor down-regulation in cofactor and
vitamin metabolism pathways (hemC, hemN-1, yggV and
folD).
Taken together, this overall down-regulation of key
pathways is suggestive of a persistence phenotype. The
normal chlamydial developmental cycle can be altered
under stressful conditions, leading to the formation of
aberrant bodies (ABs) which are inhibited in their differ-
entiation back to infectious EBs [11]. Molecular conse-
quences include a ‘blockage’ in development involving
down-regulation of late gene products in persistent
infections [19].
The omcB and trpB genes are currently the most reliable
general markers of chlamydial persistence [12-14,20-22].
The down-regulation trends reported in this project, for
these genes under estradiol supplement, were consistent
with previous data in the microarray study of IFN-g-
mediated C. trachomatis serovar D persistence [13]. It has
previously been shown that trpA and trpB are two genes
known to be involved in chlamydial persistence [12,20].
Hogan et al. [12] showed that the expression patterns of
these two genes were mostly up-regulated in chlamydial
persistence. While the expression level of trpB in our
experiment indicated a similar up-regulation, the expres-
sion levels of trpA did not change. As an additional strat-
egy, we attempted to identify chlamydial genes involved in
ADP/ATP exchange and energy source pathway reactions
in the C. trachomatis genome. This analysis revealed six
targets which may be involved in chlamydial persistence
(a) two genes encoding proteins involved in the glycolysis
pathway (pyk, yggV) (b), two genes (cydA, cydB) encoding
proteins involved in the electron transport system, and (c)
two genes encoding proteins involved in the production of
tryptophan synthase subunits. Previous data have demon-
strated that the metabolic characteristics of persistent
chlamydiae were not the same as those of actively growing
organisms [12,15-17]. The results reported from Gerard et
al. [18] indicated that during the primary phase of active
infection, C. trachomatis obtains the energy essential for
Table 3 Categorisation of the up- and down-regulated genes into pathways, as per KEGG.
Total Up-regulated Down-regulated
Estradiol Progesterone Estradiol Progesterone
Energy metabolism 14 3 4 6 4
Carbohydrate metabolism 23 2 9 1 -
Lipid metabolism 27 1 2 7 8
Nucleotide metabolism 29 - 1 16 3
Amino acid metabolism 30 3 8 3 3
Metabolism of other amino acids 4 - - - -
Metabolism of cofactors and vitamins 33 - 1 6 3
Glycan biosynthesis and metabolism 16 2 6 1 2
Biosynthesis of secondary metabolism 15 1 1 3 4
12 32 43 27
The numbers represent the number of pathways (not genes) affected following exposure with either Estradiol or progesterone.
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host cells via ATP/ADP exchange. Through active growth
of the RB, the organisms acquire ATP not only from the
host, but also via their own glycolytic and pentose phos-
phate pathways. Gerard et al. (2002) showed that through-
out the initial phase of monocyte infection, prior to the
complete establishment of persistence, C. trachomatis
cells utilized both ATP/ADP exchange and their own
pathways to support metabolic needs, even though the
overall metabolic rate in the organisms was relatively low.
However, when persistence has been established, the only
source of ATP seemed to be the host [18]. That is, mRNA
for glycolytic and pentose phosphate pathway enzymes
were absent or severely reduced, suggesting that these sys-
tems were partially, if not completely, shut down during
persistence. Therefore, C. trachomatis seems to be only
partial energy parasites on their hosts during active
growth, however during persistent infection, the organisms
appear to be completely dependent on the host for ATP.
Most notably in our current project, pyk and yggV
were strongly down-regulated (3-fold and 10-fold
respectively) following supplementation with estradiol,
which may contribute to a reduction in the rate of gly-
colysis biosynthesis during persistence. Two other well
known chlamydial persistence genes (cydA, cydB), which
play a part in the electron transport system were also
down-regulated (8-fold and 4-fold respectively) in the
presence of estradiol.
The other key persistence-suggestive change was
observed at the morphological level. It has been
previously reported by several authors [13,23,24] that
chlamydiae show abnormal morphology under persis-
tence conditions. We analysed both un-exposed as well
as hormone-exposed C. trachomatis infected ECC-1 cell
cultures using Transmission Electron Microscope
(TEM) analysis (Figure 1). Under normal cell culture
conditions (ie cell culture media supplemented with
FCS) we observed normal chlamydial inclusion growth
                                                          
  A                                               B   
   C                                              D 
Figure 1 Transmission electron micrographs of C. trachomatis inclusion development in ECC-1 cells at 48 hours under different
hormonal conditions estradiol and/or progesterone. (A) ECC-1 cells grown in normal FCS supplemented cell culture. Typical RB forms are
present at 24 hours post infection (B) No hormone supplemented stripped FCS media. Once again normal RB morphology was observed under
this condition; RBs appeared similar to normal FCS supplemented cell culture. (C) Estradiol supplemented, RBs were distinctly different, appearinga s
large aberrant form. Estradiol supplementation of infected cells, resulting in smaller inclusions containing enlarged, atypical RB forms (arrows). (D)
Progesterone supplemented, shape and morphology of RBs were normal including binary fission. Morphological examination of progesterone
exposed cultures with TEM did not show any evidence of aberrant, persistent forms. Magnification: × 20K, marker represent 200 nm.
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istic RBs and EBs of normal size and shape (Figure 1,
Panel A). By comparison, when we grew the chlamydiae
in charcoal stripped foetal calf serum (hormone free
media), supplemented with estradiol, we observed typi-
cal chlamydial persistence inclusions containing aber-
rant, enlarged RBs which had not differentiated into EBs
(Figure 1, Panel C). The morphological features that we
observed associated with hormone-mediated persistence
demonstrate similarities to those observed by others for
persistence induced by IFN-g and penicillin.
Progesterone exposure induces an up-regulated energy
utilising chlamydial response
Overall, 85 chlamydial genes were observed to have two-
fold or greater up-regulated gene expression levels in
t h ep r e s e n c eo fp r o g e s t e r o n e .T h ef i v et o pg e n e st h a t
were observed with this mRNA expression profile
encode for proton or sodium-glutamate symport protein
(gltT) [33.4 fold], the putative glycerol-3-phosphate acyl-
transferase (plsX) [16.17 fold], glucose inhibited division
protein (lplA_2) [11.9 fold], NADH-quinone reductase
complex (nqr2) [10.95 fold] and polynucleotide adenylyl-
transferase (pcnB_1) [10.75 fold]. In addition to these 85
genes, 135 chlamydial genes were observed to have a
reduced gene expression profile in response to the pre-
sence of progesterone. The five top down regulated
genes include exoribonuclease II (vacB) [67.96 fold], iso-
pentenylpyrophosphate transferase (miaA) [33.91 fold],
cysteinyl-tRNA synthetase (cysS) [33.64 fold], thiore-
doxin reductase (trxB) [33.44fold], and ribonucleotide-
diphosphate reductase subunit alpha (nrdA) [29.25 fold].
103 genes had unknown annotated functions (hypotheti-
cal genes).
By comparison to the estradiol response, which
resulted in a down-regulation of fatty acid and nucleo-
tide metabolism pathways, progesterone exposure had
no or little effect on these pathways but did result in a
significant up-regulation of the TCA cycle and glycolysis
pathways (Table 3). In some aspects the progesterone
response was opposite or counter-balancing to the estra-
diol response. Progesterone resulted in a general up-reg-
ulation of carbohydrate metabolism pathways as well as
an up-regulation of amino acid metabolism pathways.
The progesterone-mediated response mounted by
Chlamydia reflects the host’s flux of metabolites. Pro-
gesterone has been reported to have a suppressive effect
in general on estradiol [25], and after prolonged expo-
sure, it appears that Chlamydia is diverting specific
pathways to compensate. From the top five up-regulated
genes, three genes are associated with Chlamydia-speci-
fic salvage pathways: lplA_2 for regeneration of lipoic
acid; and plsX for the formation of glycerophospolipids
and phosphotidylcholine regeneration; nqr2 for the
regeneration of NAD(P)H and free-radicals. The associa-
tion with the top five down-regulated genes appears to
align with control at the transcriptional/translational
level. For example, the gene encoding miaA and cysS
have associated functions with translation, through
transfer RNA molecules. nrdA plays an important role
in nucleotide regeneration and our observation that
expression of this gene was down 29-fold, suggests that
one mechanism being employed by C. trachomatis is to
reduce cellular multiplication.
While these chlamydial transcriptome changes might
be a direct result of the effect of the hormones on the
chlamydiae it is likely that the major effects are indirect,
via the host cells. As an intracellular pathogen, most of
the chlamydial response to the hormones is most likely
an indirect response to changes in the host cells. In a
parallel study (Wan et al., manuscript submitted) we
have analysed the host cell response to these hormones
and have found a cascade of changes. It is likely there-
fore that the chlamydial transcriptome changes are in
response to these host cell changes. It is known that
hormones have a major effect on host cell innate
immune pathways. For example, the expression of anti-
microbial peptides such as human defensin 5 (HD-5
[26]), lactoferrin [27,28], and secretory leukocyte pro-
tease inhibitor (SLPI) [29] are all influenced by changes
in female sex hormones, as is the recruitment of neutro-
phils, macrophages and NK cells into the reproductive
tract [30]. Furthermore, chlamydial infection of proges-
terone-exposed endocervical cells results in increased
mRNA levels for multiple chemokines, cytokines as well
as up-regulation of various interferon pathways in these
cells (Wan et al. manuscript submitted) suggesting that
the chlamydial changes may be in response to the
altered host cell environment. In the present study we
analysed the effects of either progesterone or estradiol
separately. In reality, both hormones are continually pre-
sent, but their levels fluctuate during the various stages
of the estrous cycle. This hormonal cycling may have
the effect of causing the chlamydiae to alternate
between cycles of productive growth and cycles of per-
sistence or dormancy. Given the 28 day duration of the
human female menstrual cycle and the 2-3 day growth
cycle of C. trachomatis, such cycling is a real possibility
and may be of survival benefit to the chlamydiae.
Conclusions
This is the first study to demonstrate transcriptional
analysis of Chlamydia trachomatis genes under different
hormonal conditions. Previous studies provided evidence
that the hormonal environment at the time of pathogen
exposure can have anclinical effect on the outcome of a
microbial infection in the genital tract. In the current
experiments, we examined the effect of the hormonal
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Page 7 of 9environment on (a) C. trachomatis gene expression and
(b) the type of inclusions that develop. In our experi-
ments, evidence of long-term persistent chlamydial
infections was observed. Collectively our data suggest
that hormonal supplementation; estradiol in particular,
may directly or indirectly play an important role in the
development of chlamydial persistence. The data may
help to explain why infections are more common in the
estrogen-dominant phase of the menstrual cycle and
suggest that estradiol favours the development of persis-
tent infections that may allow Chlamydia to; (a) resist
common antibiotic therapy and (b) survive the innate
immune response to infection, thereby facilitating
repeated reactivation of infection that drives damaging
immunopathology.
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